Once-A-Month Steroid Treatment for Patients With Focal Segmental Glomerulosclerosis
Condition(s):Glomerulonephritis; Nephrotic SyndromeLast Updated:March 4, 2008Completed
Hide Studies Not Open or Pending
Condition(s):Glomerulonephritis; Nephrotic SyndromeLast Updated:March 4, 2008Completed
Condition(s):Idiopathic Membranous NephropathyLast Updated:February 17, 2022Terminated
Condition(s):Membranous NephropathyLast Updated:September 29, 2023Active, not recruiting
Condition(s):Membranous Nephropathy – PLA2R InducedLast Updated:January 11, 2023Recruiting
Condition(s):Minimal Change Disease; Nephrotic SyndromeLast Updated:February 20, 2024Active, not recruiting
Condition(s):Membranous NephropathyLast Updated:April 7, 2020Not yet recruiting
Condition(s):Nephrotic Syndrome; Glomerulonephritis; Membranous NephropathyLast Updated:September 23, 2009Completed
Condition(s):Kidney Disease; Glomerular Disease; Idiopathic Nephrotic Syndrome; Focal Segmental Glomerulosclerosis; Collapsing GlomerulopathyLast Updated:December 17, 2019Completed
Condition(s):Membranous NephropathyLast Updated:November 18, 2023Completed
Condition(s):Nephrotic Syndrome Due to Idiopathic Membranous Nephropathy; Severe Proteinuria Due to Idiopathic Membranous NephropathyLast Updated:November 21, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.